BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35123499)

  • 1. Prediction of occult tumor progression via platelet RNAs in a mouse melanoma model: a potential new platform for early detection of cancer.
    Yin Y; Jiang R; Shen M; Li Z; Yan N; Feng J; Jiang H; Lv J; Shi L; Wang L; Liu X; Zhang K; Chen D
    J Transl Med; 2022 Feb; 20(1):71. PubMed ID: 35123499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
    Xiao B; Liu L; Li A; Wang P; Xiang C; Li H; Xiao T
    Immun Inflamm Dis; 2021 Sep; 9(3):1044-1054. PubMed ID: 34077998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection.
    D'Ambrosi S; Giannoukakos S; Antunes-Ferreira M; Pedraz-Valdunciel C; Bracht JWP; Potie N; Gimenez-Capitan A; Hackenberg M; Fernandez Hilario A; Molina-Vila MA; Rosell R; Würdinger T; Koppers-Lalic D
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.
    Makielski KM; Donnelly AJ; Khammanivong A; Scott MC; Ortiz AR; Galvan DC; Tomiyasu H; Amaya C; Ward KA; Montoya A; Garbe JR; Mills LJ; Cutter GR; Fenger JM; Kisseberth WC; O'Brien TD; Weigel BJ; Spector LG; Bryan BA; Subramanian S; Modiano JF
    Lab Invest; 2021 Dec; 101(12):1585-1596. PubMed ID: 34489559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel microRNA signature for the detection of melanoma by liquid biopsy.
    Sabato C; Noviello TMR; Covre A; Coral S; Caruso FP; Besharat ZM; Splendiani E; Masuelli L; Battistelli C; Vacca A; Catanzaro G; Po A; Anichini A; Maio M; Ceccarelli M; Di Giacomo AM; Ferretti E
    J Transl Med; 2022 Oct; 20(1):469. PubMed ID: 36243798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
    Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis.
    Guan M; Chen X; Ma Y; Tang L; Guan L; Ren X; Yu B; Zhang W; Su B
    Tumour Biol; 2015 Apr; 36(4):2973-82. PubMed ID: 25480418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.
    Wei CY; Zhu MX; Lu NH; Liu JQ; Yang YW; Zhang Y; Shi YD; Feng ZH; Li JX; Qi FZ; Gu JY
    Mol Cancer; 2020 May; 19(1):84. PubMed ID: 32381016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
    Zhao CC; Guo H; Wang Y; Li JH
    Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.